Trials / Conditions / SMARCA4-Deficient Tumor
SMARCA4-Deficient Tumor
4 registered clinical trials studyying SMARCA4-Deficient Tumor — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Adva NCT07307443 | Zhijie Wang | Phase 2 |
| Not Yet Recruiting | A Phase II Study of QL1706 and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advance NCT07200947 | Zhijie Wang | Phase 2 |
| Recruiting | A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors NCT06561685 | Eli Lilly and Company | Phase 1 |
| Completed | A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer NCT07121387 | Shanghai Pulmonary Hospital, Shanghai, China | — |